Overview

Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis

Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
To evaluate if transcranial magnetic stimulation can be used as a biomarker in Amyotrophic Lateral sclerosis (ALS).
Phase:
Early Phase 1
Details
Lead Sponsor:
Mayo Clinic